Atlas Trials

Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation

Clinical trial NCT02845453 · COMPLETED

Trial details

NCT number
NCT02845453
Sponsor
Boston Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Substance Use DisordersBipolar DisorderMood Disorders
Start date
2017-01-20
Primary completion
2021-04-07
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.